Pfizer has recalled two lots of migraine drug Relpax.
FDA warns Chinese co. for data integrity violations
The agency posted a warning letter to Ningbo Huize Commodity, an OTC drug manufacturer.
A potential new blockbuster from AbbVie has gotten the go-ahead from the FDA.
Vanda Pharma announced that it has received a complete response letter from the FDA for Hetlioz.
The U.S. FDA has approved Celgene's rare bone marrow cancer drug, Inrebic.
Don't miss your Daily Dose. Get news like this delivered right to your inbox.